- Stocks
- Healthcare
- NASDAQ: HQY

Price (delayed)

$78.51

Market cap

$6.55B

P/E Ratio

1,308.5

Dividend/share

N/A

EPS

$0.06

Enterprise value

$6.87B

HQY's quick ratio has surged by 136% year-on-year and by 115% since the previous quarter

The equity has soared by 78% YoY and by 34% from the previous quarter

The P/E is 139% higher than the 5-year quarterly average of 547.6

HQY's EPS has dropped by 50% since the previous quarter

What are the main financial stats of HQY

Market
Valuations
Earnings

Shares outstanding

83.39M

Market cap

$6.55B

Enterprise value

$6.87B

Price to earnings (P/E)

1,308.5

Price to book (P/B)

3.53

Price to sales (P/S)

8.82

EV/EBIT

271.07

EV/EBITDA

47.2

EV/Sales

9.44

Revenue

$727.76M

EBIT

$25.34M

EBITDA

$145.5M

Free cash flow

$134.25M

Per share
Balance sheet
Liquidity

EPS

$0.06

Free cash flow per share

$1.64

Book value per share

$22.26

Revenue per share

$8.9

TBVPS

$12.45

Total assets

$3.16B

Total liabilities

$1.31B

Debt

$1.06B

Equity

$1.85B

Working capital

$672.81M

Debt to equity

0.57

Current ratio

4.5

Quick ratio

4.22

Net debt/EBITDA

2.21

Margins
Efficiency
Dividend

EBITDA margin

20%

Gross margin

56.4%

Net margin

0.6%

Operating margin

3.2%

Return on assets

0.2%

Return on equity

0.3%

Return on invested capital

2.1%

Return on capital employed

0.9%

Return on sales

3.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Healthequity stock price performed over time

Intraday

0.68%

1 week

-3.19%

1 month

8.8%

1 year

39.65%

YTD

12.62%

QTD

15.46%

How have Healthequity's revenue and profit performed over time

Revenue

$727.76M

Gross profit

$410.38M

Operating income

$23.2M

Net income

$4.39M

Gross margin

56.4%

Net margin

0.6%

Healthequity's operating margin has plunged by 68% YoY and by 30% from the previous quarter

HQY's operating income has dropped by 64% year-on-year and by 32% since the previous quarter

HQY's net income has dropped by 50% since the previous quarter

The net margin has dropped by 50% since the previous quarter

What is Healthequity's growth rate over time

What is Healthequity stock price valuation

P/E

1,308.5

P/B

3.53

P/S

8.82

EV/EBIT

271.07

EV/EBITDA

47.2

EV/Sales

9.44

The P/E is 139% higher than the 5-year quarterly average of 547.6

HQY's EPS has dropped by 50% since the previous quarter

The equity has soared by 78% YoY and by 34% from the previous quarter

The stock's P/B is 50% below its 5-year quarterly average of 7.1 but 3.8% above its last 4 quarters average of 3.4

The stock's price to sales (P/S) is 28% more than its last 4 quarters average of 6.9 but 28% less than its 5-year quarterly average of 12.2

HQY's revenue is up by 15% year-on-year

How efficient is Healthequity business performance

The ROE has plunged by 57% from the previous quarter

HQY's return on sales is down by 34% since the previous quarter and by 29% year-on-year

The ROA has contracted by 33% from the previous quarter

HQY's ROIC is down by 32% QoQ and by 25% YoY

What is HQY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for HQY.

How did Healthequity financials performed over time

Healthequity's total assets is 141% higher than its total liabilities

HQY's quick ratio has surged by 136% year-on-year and by 115% since the previous quarter

Healthequity's current ratio has surged by 113% YoY and by 100% QoQ

The debt is 43% smaller than the equity

The equity has soared by 78% YoY and by 34% from the previous quarter

The debt to equity has dropped by 55% year-on-year and by 27% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.